Biocompatible near-infrared quantum dots delivered to the skin by microneedle patches record vaccination.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
18 12 2019
Historique:
received: 20 07 2019
accepted: 27 11 2019
entrez: 20 12 2019
pubmed: 20 12 2019
medline: 15 9 2020
Statut: ppublish

Résumé

Accurate medical recordkeeping is a major challenge in many low-resource settings where well-maintained centralized databases do not exist, contributing to 1.5 million vaccine-preventable deaths annually. Here, we present an approach to encode medical history on a patient using the spatial distribution of biocompatible, near-infrared quantum dots (NIR QDs) in the dermis. QDs are invisible to the naked eye yet detectable when exposed to NIR light. QDs with a copper indium selenide core and aluminum-doped zinc sulfide shell were tuned to emit in the NIR spectrum by controlling stoichiometry and shelling time. The formulation showing the greatest resistance to photobleaching after simulated sunlight exposure (5-year equivalence) through pigmented human skin was encapsulated in microparticles for use in vivo. In parallel, microneedle geometry was optimized in silico and validated ex vivo using porcine and synthetic human skin. QD-containing microparticles were then embedded in dissolvable microneedles and administered to rats with or without a vaccine. Longitudinal in vivo imaging using a smartphone adapted to detect NIR light demonstrated that microneedle-delivered QD patterns remained bright and could be accurately identified using a machine learning algorithm 9 months after application. In addition, codelivery with inactivated poliovirus vaccine produced neutralizing antibody titers above the threshold considered protective. These findings suggest that intradermal QDs can be used to reliably encode information and can be delivered with a vaccine, which may be particularly valuable in the developing world and open up new avenues for decentralized data storage and biosensing.

Identifiants

pubmed: 31852802
pii: 11/523/eaay7162
doi: 10.1126/scitranslmed.aay7162
pmc: PMC7532118
mid: NIHMS1631057
pii:
doi:

Substances chimiques

Sulfides 0
Zinc Compounds 0
zinc sulfide KPS085631O

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIBIB NIH HHS
ID : F32 EB022416
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014051
Pays : United States

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Lancet Infect Dis. 2019 Feb;19(2):177-184
pubmed: 30558994
Eur J Pediatr. 2019 Feb;178(2):243-251
pubmed: 30430239
BMJ Open Diabetes Res Care. 2016 Dec 15;4(1):e000266
pubmed: 28074137
Appl Opt. 1971 Aug 1;10(8):1914-8
pubmed: 20111227
J Neurosci Nurs. 2015 Feb;47(1):E22-30
pubmed: 25225835
Comput Methods Programs Biomed. 2015 Nov;122(2):215-28
pubmed: 26363678
Nat Nanotechnol. 2009 Nov;4(11):710-1
pubmed: 19898521
J Control Release. 2016 Jul 10;233:101-13
pubmed: 27178811
Ann Biomed Eng. 2012 Feb;40(2):516-33
pubmed: 22045511
Vaccine. 2017 Apr 19;35(17):2265-2271
pubmed: 28364941
Lancet. 2010 Jun 5;375(9730):1969-87
pubmed: 20466419
Diagnostics (Basel). 2014 Aug 18;4(3):104-28
pubmed: 26852680
Annu Rev Chem Biomol Eng. 2017 Jun 7;8:177-200
pubmed: 28375775
Pharmaceutics. 2018 Dec 06;10(4):
pubmed: 30563197
PLoS One. 2019 Jan 24;14(1):e0210648
pubmed: 30677072
Adv Mater. 2018 May;30(18):e1706356
pubmed: 29468747
Lancet Infect Dis. 2019 Feb;19(2):185-192
pubmed: 30635255
ACS Nano. 2017 Jan 24;11(1):153-162
pubmed: 27997116
J Am Chem Soc. 2012 May 2;134(17):7207-10
pubmed: 22515639
J Am Chem Soc. 2011 Feb 9;133(5):1176-9
pubmed: 21207995
Chem Rev. 2016 Sep 28;116(18):10623-730
pubmed: 27586892
Lancet. 2017 Aug 12;390(10095):649-658
pubmed: 28666680
Eur J Pharm Biopharm. 2015 Jan;89:224-31
pubmed: 25481031
Drug Deliv Transl Res. 2015 Aug;5(4):360-71
pubmed: 25895053
Methods Mol Biol. 2016;1387:145-76
pubmed: 26983734
Clin J Pain. 2008 Sep;24(7):585-94
pubmed: 18716497
Small. 2009 Feb;5(2):154-68
pubmed: 19153991
J Pharm Sci. 2013 Apr;102(4):1209-21
pubmed: 23359221
J Am Chem Soc. 2008 Jul 23;130(29):9240-1
pubmed: 18582061
Vaccine. 2013 Mar 15;31(12):1560-8
pubmed: 23196207
ACS Nano. 2018 Oct 23;12(10):10272-10280
pubmed: 30272942
J Exp Med. 2018 Apr 2;215(4):1115-1133
pubmed: 29511065
J Public Health Manag Pract. 1996 Winter;2(1):18-25
pubmed: 10186652
J Diabetes Sci Technol. 2007 Sep;1(5):725-9
pubmed: 19885141
Biomaterials. 2014 Feb;35(5):1608-17
pubmed: 24239108
Microsyst Nanoeng. 2017 Oct 09;3:17034
pubmed: 31057872
Saf Health Work. 2013 Mar;4(1):12-26
pubmed: 23516020
J Am Chem Soc. 2015 Oct 7;137(39):12430-3
pubmed: 26389704
Am J Public Health. 1992 Jan;82(1):120-2
pubmed: 1536315
J Control Release. 2012 Jul 10;161(1):10-7
pubmed: 22306332
Somatosens Mot Res. 2006 Mar-Jun;23(1-2):37-43
pubmed: 16846958
Glob Health Action. 2013 Apr 30;6:20343
pubmed: 23639178
Sci Rep. 2017 Nov 21;7(1):15885
pubmed: 29162871
Sci Transl Med. 2019 Dec 18;11(523):
pubmed: 31852802
J Cutan Aesthet Surg. 2015 Jan-Mar;8(1):16-24
pubmed: 25949018
Vaccine. 2018 Oct 22;36(44):6567-6577
pubmed: 29162321
JAMA Dermatol. 2015 Nov;151(11):1194-9
pubmed: 26352252
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Int J Qual Health Care. 2012 Dec;24(6):564-7
pubmed: 22798693
Adv Drug Deliv Rev. 1997 Oct 13;28(1):5-24
pubmed: 10837562
Nat Mater. 2016 Feb;15(2):235-42
pubmed: 26595119
BMC Pediatr. 2015 Apr 01;15:31
pubmed: 25886255
J Biomed Opt. 2015 Mar;20(3):030901
pubmed: 25803186

Auteurs

Kevin J McHugh (KJ)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Lihong Jing (L)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
Key Laboratory of Colloid, Interface and Chemical Thermodynamics, Institute of Chemistry, Chinese Academy of Sciences, Bei Yi Jie 2, Zhong Guan Cun, Beijing 100190, China.

Sean Y Severt (SY)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Mache Cruz (M)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Morteza Sarmadi (M)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
Department of Mechanical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Hapuarachchige Surangi N Jayawardena (HSN)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Collin F Perkinson (CF)

Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Fridrik Larusson (F)

Global Good, Intellectual Ventures Laboratory, 14360 SE Eastgate Way, Bellevue, WA 98007, USA.

Sviatlana Rose (S)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Stephanie Tomasic (S)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Tyler Graf (T)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Stephany Y Tzeng (SY)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

James L Sugarman (JL)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Daniel Vlasic (D)

Independent consultant, 119 Kendall Rd, Lexington, MA 02421, USA (https://people.csail.mit.edu/drdaniel/).

Matthew Peters (M)

Global Good, Intellectual Ventures Laboratory, 14360 SE Eastgate Way, Bellevue, WA 98007, USA.

Nels Peterson (N)

Global Good, Intellectual Ventures Laboratory, 14360 SE Eastgate Way, Bellevue, WA 98007, USA.

Lowell Wood (L)

Global Good, Intellectual Ventures Laboratory, 14360 SE Eastgate Way, Bellevue, WA 98007, USA.

Wen Tang (W)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Jihyeon Yeom (J)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Joe Collins (J)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Philip A Welkhoff (PA)

Institute for Disease Modeling, 3150 139th Ave. SE, Bellevue, WA 98005, USA.

Ari Karchin (A)

Global Good, Intellectual Ventures Laboratory, 14360 SE Eastgate Way, Bellevue, WA 98007, USA.

Megan Tse (M)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Mingyuan Gao (M)

Key Laboratory of Colloid, Interface and Chemical Thermodynamics, Institute of Chemistry, Chinese Academy of Sciences, Bei Yi Jie 2, Zhong Guan Cun, Beijing 100190, China.

Moungi G Bawendi (MG)

Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.

Robert Langer (R)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. rlanger@mit.edu jaklenec@mit.edu.

Ana Jaklenec (A)

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. rlanger@mit.edu jaklenec@mit.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH